Eagle Pharmaceuticals, Inc. to Present at Investor Conferences in June

WOODCLIFF LAKE, N.J.--()--Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (NASDAQ: EGRX) announced today that management will present at two investor conferences in June as follows:

     

Conference:

Jefferies 2018 Global Healthcare Conference

Date: Thursday, June 7, 2018
Time: 1:30 p.m. Eastern Daylight Time
Location: Grand Hyatt New York, NYC

Presenters:

Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer

Webcast:

http://wsw.com/webcast/jeff113/egrx/

 
     

Conference:

William Blair 38th Annual Growth Stock Conference

Date: Tuesday, June 12, 2018
Time: 3:30 p.m. Central Daylight Time
Location: Four Seasons Hotel, Chicago

Presenters:

David Pernock, President and Chief Commercial Officer, and Pete Meyers, Chief Financial Officer

Webcast:

http://wsw.com/webcast/blair54/egrx/

 

The presentations will be webcast live at the aforementioned times, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors + News Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the Company’s website at www.eagleus.com.

Contacts

Investor Relations for Eagle Pharmaceuticals, Inc:
Lisa M. Wilson, 212-452-2793
lwilson@insitecony.com

Contacts

Investor Relations for Eagle Pharmaceuticals, Inc:
Lisa M. Wilson, 212-452-2793
lwilson@insitecony.com